Mevion touts first use of S250i proton therapy system

Mevion Medical Systems today announced the launch of its Mevion S250i proton therapy system, touting that the first patient in the world had been treated with the system.

The Mevion S250i features improved pencil beam scanning fields and Hyperscan pencil beam scanning tech to allow for faster energy layer switching, the Littleton, Mass.-based company said.

The system also features the company’s Adaptive Aperture multi-leaf collimator designed for multi-layer conformal field delivery, Mevion said, which it claims provides dose gradients with up to 3 times sharper lateral penumbra.

“The launch of the Hyperscan system is a major milestone in the field of proton therapy. It is the realization of a vision to create the most clinically advanced and economically viable proton therapy system in the world making proton therapy accessible across the spectrum of healthcare providers. Mevion has consistently pushed the field of proton therapy forward. We first changed proton therapy by introducing a new paradigm of economic, compact proton systems and now we are doing it again by deploying an advanced approach to pencil beam delivery. These achievements are the result of a team passionate about the impact proton therapy can have on patients’ lives,” CEO Joseph Jachinowski said in a press release.

Mevion said that it is actively installing the system at centers throughout the US and Europe, with two more Hyperscan centers slated to be functional and treating patients by the end of 2018

“We are excited to see the rapid adoption of Mevion’s Hyperscan technology. Proton therapy has long been viewed as economically unrealistic for most cancer centers. The uptick in proton projects and repeat customers speaks to the strength of the Mevion economic and clinical approach,” Mevion sales senior VP Yoel Bakas said in a prepared statement.

In January, Mevion said it won FDA 510(k) clearance for its Mevion S250i proton therapy system featuring pencil beam scanning technology, and touted that the first unit was installed at MedStar Georgetown University Hospital in Washington D.C.

The post Mevion touts first use of S250i proton therapy system appeared first on MassDevice.

from MassDevice https://ift.tt/2q0I2jN